TD is a movement disorder that can develop in individuals who take certain medications, especially those used to treat mental health conditions, for an extended period. It manifests as involuntary and often repetitive movements in different parts of the body.
There are two FDA-approved brand-name drugs that can treat tardive dyskinesia: Ingrezza (valbenazine) and Austedo (deutetrabenazine). You can talk to your doctor about taking these treatments alongside your current mental health treatment.
While the exact cause of TD remains under investigation, research suggests a strong link between certain medications and its development. The risk of developing TD increases the longer a person takes these medications.
individuals taking specific antipsychotic medications may develop TD.2
symptoms can appear after starting these medications.3
Only a medical professional can diagnose TD. If you suspect you might have it, click below to complete a TDScreen and get results you can share with your healthcare provider. Please do not start or stop any medications or treatment plans without consulting with your provider.
Get FREE Virtual ScreeningThe TDScreen tool is based on the Abnormal Involuntary Movement Scale (AIMS), a comprehensive clinician-rated scale designed to specifically evaluate orofacial movements. Employing advanced AI video technology, TDScreen efficiently assesses and quantifies the risk of tardive dyskinesia in less than 5 minutes. The resulting score generated by this assessment can be communicated with your healthcare provider to aid in clinical decision-making and management strategies.
TDScreen estimates your risk for TD and share results with your provider
TDScreen was made with you in mind. It's simple and takes less than 5 minutes.
To see your movements, you will be asked to record short video responses. It's easy!
1 in 4 patients who have been prescribed antipsychotics are at risk of TD, which if caught early, can be treatable. TDScreen is a seamless solution for psychiatric providers seeking to enhance patient care.
With TDScreen, your patients on antipsychotics can easily and naturally complete virtual screenings in their own environments to accurately assess their risk factors and to enable you to monitor or modify their treatment plans.
Effortlessly enroll patient cohorts receiving antipsychotics for automated TDScreen assessments at predetermined intervals, ensuring proactive healthcare management.
Our intuitive interface simplifies scheduling tailored screening and monitoring protocols, accompanied by automated reminders and notifications to keep both providers and patients engaged every step of the way.
Clinicians can now access our FREE online platform, TDScreen, designed to streamline TD risk assessment and improve patient care.
Seamlessly integrate automated TDScreen protocols alongside other essential screening and monitoring programs (additional fees may apply).
